P2Y12 inhibition in acute coronary syndromes treated with percutaneous intervention – Understanding the debate on Prasugrel or Ticagrelor

2021 ◽  
pp. 108029
Author(s):  
Andreas Schäfer ◽  
Johann Bauersachs
2019 ◽  
Vol 8 ◽  
pp. 204800401986916
Author(s):  
Giampiero Vizzari ◽  
Francesco Versaci ◽  
Antonino Nicosia

Neurological and cardiovascular ischemic diseases represent the main causes of morbidity and mortality in the world. Physiopathological mechanisms present several similarities, based on “thromboembolic” events, as well as the pharmacological and percutaneous treatment options. We report a case of contemporary presentation of acute coronary and cerebral syndromes, successfully managed with a combined percutaneous intervention driven by the emergency setting. Whereas invasive revascularization represents nowadays the “gold standard” therapy for acute coronary syndromes, catheter-based treatment of acute stroke is not yet widespread and still under debate.


Sign in / Sign up

Export Citation Format

Share Document